Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global clinical data management system market was valued at 4.08 billion in 2024 and is expected to reach US$ 10.35 billion by 2033, growing at a CAGR of ...

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

Veeva Systems Inc. VEEV recently announced the availability of a novel solution for aggregating, cleaning and transforming clinical data, Veeva CDB (clinical database). The new clinical data ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

Clinical trials are generating more data than ever and researchers need systems capable of recording, storing and managing the additional information, says tech firm Medidata. The Dassault ...

The evaluation highlights Oracle's strengths in providing a comprehensive solution to critical trial management and its abilities to accommodate diverse regulatory requirements globally. The report ...

Mergers and acquisitions (M&As) are highly prevalent in the healthcare industry—a trend that will likely continue into the foreseeable future. The first half of 2024 saw 31 announced hospital M&As, ...

Health systems are adopting a range of strategies to strengthen collaboration between clinical and supply chain teams, such as implementing formal governance structures, data-driven disruption ...

As clinical trials grow more global and complex, AI is emerging as a practical enabler of smarter financial management by automating manual processes, improving visibility across fragmented systems, ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

(MENAFN- GlobeNewsWire - Nasdaq) Growth is being driven by the increasing complexity of clinical trials, the rising volume of trial data, and the urgent need for streamlined, accurate, and secure data ...